1. World Health Organization. Hepatitis C Key facts. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
2.
Hofstraat SHI, Falla AM, Duffell EF, et al. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiol Infect 2017; 145: 2873-2885.
3.
European Centre for Disease Prevention and Control. Hepatitis C. In: ECDC. Annual epidemiological report for 2021. 2022. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/AER-HEP-C-2021.pdf
4.
Tolmane I, Rozentale B, Keiss J, et al. The prevalence of viral hepatitis C in Latvia: a population-based study. Medicina 2011; 47: 76.
5.
Tolmane I, Upmace I, Azina I, Rozentale B. 1235. Anti-HCV prevalence and associated risk factors in patients of psychiatry hospitals in Latvia. Open Forum Infect Dis 2022; 9 (Suppl 2): ofac492-1067.
6.
World Health Organization. Fact sheet. Hepatitis C in the WHO European Region. 2022. Available from: https://www.who.int/docs/librariesprovider2/default-document-library/hepatitis-c-in-the-who-european-region-factsheet-july-2022.pdf?sfvrsn=1e330371_3&download=true
7.
Axley P, Ahmed Z, Ravi S, Singal AK. Hepatitis C virus and hepatocellular carcinoma: a narrative review. J Clin Transl Hepatol 2018; 6: 79.
8.
Jančorienė L, Rozentāle B, Tolmane I, et al. Genotype distribution and characteristics of chronic hepatitis C infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C study. Medicina 2023; 59: 1577.
9.
Tolmane I, Rozentāle B, Ažiņa I, et al. Towards the goal of hepatitis C elimination in Latvia – using patient survey results. Proc Latv Acad Sci Sect B 2022; 76: 239-245.
10.
Centers for Disease Control and Prevention. Health care Associated Hepatitis B and C Outbreaks (≥ 2 cases) Reported to the Centers for Disease Control and Prevention (CDC) 2008-2019. 2023. Available from: https://www.cdc.gov/hepatitis/outbreaks/healthcarehepoutbreaktable.htm
11.
Calles DL, Collier MG, Khudyakov Y, et al. Hepatitis C virus transmission in a skilled nursing facility, North Dakota, 2013. Am J Infect Control 2017; 45: 126-132.
12.
Thompson ND, Barry V, Alelis K, et al. Evaluation of the potential for bloodborne pathogen transmission associated with diabetes care practices in nursing homes and assisted living facilities, Pinellas County. J Am Geriatr Soc 2010; 58: 914-918.
13.
Nikoo N, Javidanbardan S, Akm M, et al. Hepatitis C prevalence and associated risk factors among individuals who are homeless and diagnosed with mental illness: at Home/Chez Soi Study, Vancouver, BC. Eur J Public Health 2019; 29: 242-247.
14.
Khalili M, Powell J, Park HH, et al. Shelter-based integrated model is effective in scaling up hepatitis C testing and treatment in persons experiencing homelessness. Hepatol Commun 2021; 6: 50-64.
15.
Leach M, Chapin S, Porges I, et al. Evaluation of risk factors for hepatitis C virus infection among Philadelphia’s shelter-bound, homeless population: data from a student-run hepatitis C virus screening initiative. Popul Health Manag 2021; 24: 448-453.
16.
Bashir AY, Moloney N, Elzain ME, et al. From nowhere to nowhere. Homelessness and incarceration: a systematic review and meta-analysis. Int J Prison Health 2021; 17: 452-461.
17.
Brown MA, Gellatley W, Hoffman A, et al. Medical complications of homelessness: a neglected side of men’s health. Intern Med J 2019; 49: 455-460.
18.
Lambert JS, Murtagh R, Menezes D, et al. ‘HepCheck Dublin’: an intensified hepatitis C screening programme in a homeless population demonstrates the need for alternative models of care. BMC Infect Dis 2019; 19: 1-9.
19.
European Centre for Disease Prevention and Control. Facts about hepatitis C. 2017. Available from: https://www.ecdc.europa.eu/en/hepatitis-c/facts
20.
White DA, Anderson ES, Pfeil SK, et al. Results of a rapid hepatitis C virus screening and diagnostic testing program in an urban emergency department. Ann Emerg Med 2016; 67: 119-128.
21.
Caccamo G, Brischetto D, Alibrandi A, et al. Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in southern Italy. J Gerontol Geriatr 2019; 67: 244-248.
22.
Andriulli A, Stroffolini T, Mariano A, et al. Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas. Eur J Intern Med 2018; 53: 79-84.
23.
Gallo P, Di Francesco S, De Vincentis A, et al. Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population. J Hosp Infect 2023. DOI: 10.1016/j.jhin.2023.02.028
24.
Alvarez KJ, Smaldone A, Larson EL. Burden of hepatitis C virus infection among older adults in long-term care settings: a systematic review of the literature and meta-analysis. Curr Infect Dis Rep 2016; 18: 1-8.
25.
Aisyah DN, Shallcross L, Hayward A, et al. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London. J Viral Hepat 2018; 25: 1260-1269.
26.
Chien NT, Dundoo G, Horani MH, et al. Seroprevalence of viral hepatitis in an older nursing home population. J Am Geriatr Soc 1999; 47: 1110-1113.
27.
Falade-Nwulia O, Irvin R, McAdams-Mahmoud A, et al. Senior center-based hepatitis C screening in Baltimore. Open Forum Infect Dis 2016; 3: ofv217.
28.
Hagan LM, Kasradze A, Salyer SJ, et al. Hepatitis C prevalence and risk factors in Georgia, 2015: setting a baseline for elimination. BMC Public Health 2019; 19: 1-12.
29.
U.S. Department of Health and Human Services. Hepatitis C Basic Information. 2022. Available from: https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/hepatitis-c-basics/index.html
30.
Abdel-Gawad M, Nour M, El-Raey F, et al. Gender differences in prevalence of hepatitis C virus infection in Egypt: a systematic review and meta-analysis. Sci Rep 2023; 13: 2499.
31.
Al-Nassary MSK, Mahdi BM. Study of hepatitis C virus detection assays. Ann Med Surg 2018; 36: 47-50.
32.
World Health Organization. 2022. Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
